pulmonologyadvisor2d
FDA Approves More Broadly Protective Meningococcal Vaccine
The US FDA has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for active immunization against invasive meningococcal disease.
MedPage Today28d
Biden Stacked Vaccine Committee; Sickle Cell and Sudden Death; NFL Concussions Down
(New York Times) In Texas, at least four measles cases have been reported amid falling vaccination rates in ... There is no evidence of a link between sickle cell trait and sudden death, a ...
Healio11d
FDA approves GSK’s pentavalent meningococcal vaccine
Penmenvy protects against meningococcal serotypes A, B, C, W and Y. CDC vaccine advisors are set to discuss recommendations for the vaccine on Feb. 26. The FDA approved GSK’s pentavalent ...
WebMD10d
FDA Approves 5-in-1 Vaccine Against Meningococcal Disease
These studies showed that the vaccine is effective, safe, and well-tolerated, with a safety profile similar to GSK’s licensed meningococcal vaccines, according to the news release by GSK.
Benzinga.com9d
FDA Approves GSK's 5-in-1 Meningococcal Vaccine For Adolescents Ahead Of CDC Advisory Committee Vote Meeting Next Week
The FDA approved GSK's Penmenvy vaccine for ages 10-25, targeting five major meningococcal serogroups: A, B, C, W, and Y. Phase 3 trials with 4,800 participants showed the vaccine has a safety ...
pharmaphorum3d
GSK trails after Pfizer in 5-in-1 meningococcal vaccine race
The FDA has started a review of GSK’s five-in-one meningococcal vaccine, cueing up a decision in mid-February next year, as it tries to chase down a rival candidate from Pfizer cleared last year.
Yahoo Finance11d
PENMENVY, GSK’s 5-in-1 Meningococcal Vaccine, Approved by US FDA to Help Protect Against MenABCWY
Tony Wood, Chief Scientific Officer, GSK, said: "We are excited about the opportunities ahead to help improve meningococcal vaccination coverage in the United States, especially for IMD caused by ...
Nasdaq11d
FDA Approves GSK's Penmenvy, 5-in-1 Meningococcal Vaccine For MenABCWY Protection
(RTTNews) - GSK plc (GSK, GSK.L) announced that the US Food and Drug Administration has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for use in individuals aged 10 through 25 ...
Medical Xpress10d
FDA approves more broadly protective meningococcal vaccine
The FDA has approved Penmenvy, a vaccine for individuals aged 10 to 25, targeting five major serogroups of Neisseria meningitidis (A, B, C, W, and Y), which cause invasive meningococcal disease ...
Yahoo Finance9d
FDA Approves GSK's 5-in-1 Meningococcal Vaccine For Adolescents Ahead Of CDC Advisory Committee Vote Meeting Next Week (UPDATED)
On Friday, February 14, the FDA approved GSK plc’s (NYSE:GSK) Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for use in individuals aged 10 through 25. The vaccine targets five major ...
The Daily Gazette10d
FDA Approves More Broadly Protective Meningococcal Vaccine
TUESDAY, Feb. 18, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for active immunization against invasive ...